跳至主要内容
临床试验/CTRI/2019/06/019778
CTRI/2019/06/019778尚未招募3 期

A comparative study of oral terbinafine versus oral terbinafine and griseofulvin in tinea

Institute of Medical Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients with clinical diagnosis of tinea corporis, tinea cruris or tinea faciei or a combination of these conditions
  • 2. Microscopic confirmation of diagnosis

排除标准

  • (a) pregnancy
  • (b) lactation
  • (c) tinea elsewhere, eg, onychomycosis
  • (d) another skin disease at the same site
  • (e) inability to come for follow up
  • (f) intake of terbinafine or griseofulvin in past 1 month
  • (g) history of allergy to terbinafine or griseofulvin
  • (h) present history of liver, renal or ischemic heart disease
  • (i) patients on treatment with drugs that have interaction with terbinafine or griseofulvin
  • (j) patient requiring antihistamines due to co-existing skin diseases as urticaria
  • (k) abnormal CBC (Hb <9, platelet count < 1 lakh), LFT, RFT, plasma glucose (fasting and postprandial), HbA1C, fasting lipid profile, urine routine and microscopy, ECG
  • (l) patients on treatment from skin OPD who is satisfied with the treatment.

研究者

发起方
Institute of Medical Sciences

相似试验

Treatment of ringworm (a fungal infection of skin)... | 临床试验